company_name,company_ticker,company_lei,company_cik,year,quarter,start_date,end_date,filing_date,parent,tag,financial_name,factor,balance,unit,value
Adverum Biotechnologies Inc,ADVM,,0001501756,2013.0,Q3,2013-07-01,2013-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-813000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-813000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,7000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,5000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,140000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,71000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-590000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2013.0,Q3,2013-07-01,2013-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-590000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-1000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2013.0,Q3,2013-07-01,2013-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-1000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2013.0,Q3,2013-07-01,2013-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-1000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,700000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,700000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2013.0,Q3,2013-07-01,2013-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,700000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2013.0,Q3,2013-07-01,2013-09-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-2000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2013.0,Q3,2013-07-01,2013-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,107000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2013.0,Q4,2013-10-01,2013-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-3693000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-3693000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,8000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,-14000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,2659000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,319000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-721000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2013.0,Q4,2013-10-01,2013-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-721000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-9000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2013.0,Q4,2013-10-01,2013-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-9000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2013.0,Q4,2013-10-01,2013-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-9000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingfinancingactivities,issuanceofpreferredequity,Issuance of Preferred Equity,+,debit,usd,1000000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-20000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,980000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2013.0,Q4,2013-10-01,2013-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,980000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2013.0,Q4,2013-10-01,2013-12-31,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,16000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2013.0,Q4,2013-10-01,2013-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,266000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2014.0,Q1,2014-01-01,2014-03-31,2015-05-13 16:12:33+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-1663000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2014.0,Q1,2014-01-01,2014-03-31,2015-05-13 16:12:33+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-1663000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2014.0,Q1,2014-01-01,2014-03-31,2015-05-13 16:12:33+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,9000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2014.0,Q1,2014-01-01,2014-03-31,2015-05-13 16:12:33+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,235000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2014.0,Q1,2014-01-01,2014-03-31,2015-05-13 16:12:33+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,72000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2014.0,Q1,2014-01-01,2014-03-31,2015-05-13 16:12:33+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-1347000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2014.0,Q1,2014-01-01,2014-03-31,2015-05-13 16:12:33+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-1347000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2014.0,Q1,2014-01-01,2014-03-31,2015-05-13 16:12:33+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-47000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2014.0,Q1,2014-01-01,2014-03-31,2015-05-13 16:12:33+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-47000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2014.0,Q1,2014-01-01,2014-03-31,2015-05-13 16:12:33+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-47000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2014.0,Q1,2014-01-01,2014-03-31,2015-05-13 16:12:33+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,1000000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2014.0,Q1,2014-01-01,2014-03-31,2015-05-13 16:12:33+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,1000000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2014.0,Q1,2014-01-01,2014-03-31,2015-05-13 16:12:33+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,1000000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2014.0,Q1,2014-01-01,2014-03-31,2015-05-13 16:12:33+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-1000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2014.0,Q1,2014-01-01,2014-03-31,2015-05-13 16:12:33+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-395000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2014.0,Q1,2014-01-01,2014-03-31,2015-05-13 16:12:33+00:00,,cashinterestpaid,Cash Interest Paid,=,,usd,5000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2014.0,Q2,2014-04-01,2014-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-5094000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-5094000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,25000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1981000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,8815000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,5727000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2014.0,Q2,2014-04-01,2014-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,5727000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-427000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2014.0,Q2,2014-04-01,2014-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-427000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2014.0,Q2,2014-04-01,2014-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-427000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingfinancingactivities,repurchaseofpreferredequity,Repurchase of Preferred Equity,+,debit,usd,-6540000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-408000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,1000000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingfinancingactivities,issuanceofpreferredequity,Issuance of Preferred Equity,+,debit,usd,52905000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,46957000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2014.0,Q2,2014-04-01,2014-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,46957000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2014.0,Q2,2014-04-01,2014-06-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,2000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2014.0,Q2,2014-04-01,2014-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,52259000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2014.0,Q2,2014-04-01,2014-06-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,-5000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2014.0,Q3,2014-07-01,2014-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-8256000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-8256000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,49000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,3448000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-214000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-4973000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2014.0,Q3,2014-07-01,2014-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-4973000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-105000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2014.0,Q3,2014-07-01,2014-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-105000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2014.0,Q3,2014-07-01,2014-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-105000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,408000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,116973000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,609000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,117990000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2014.0,Q3,2014-07-01,2014-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,117990000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2014.0,Q3,2014-07-01,2014-09-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-11000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2014.0,Q3,2014-07-01,2014-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,112901000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 16:31:25+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-9509000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 16:31:25+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-9509000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 16:31:25+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,118000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 16:31:25+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,59000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 16:31:25+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,906000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 16:31:25+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,684000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 16:31:25+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-7742000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 16:31:25+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-7742000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 16:31:25+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-411000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 16:31:25+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-88370000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 16:31:25+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-88781000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 16:31:25+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-88781000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 16:31:25+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,138954000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 16:31:25+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,21000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 16:31:25+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,138975000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 16:31:25+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,138975000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 16:31:25+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-7000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 16:31:25+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,42445000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2015.0,Q2,2015-04-01,2015-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-9766000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-9766000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,147000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,258000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,655000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-544000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-9250000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2015.0,Q2,2015-04-01,2015-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-9250000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-1074000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-59000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,8960000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2015.0,Q2,2015-04-01,2015-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,7827000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2015.0,Q2,2015-04-01,2015-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,7827000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,110000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,110000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2015.0,Q2,2015-04-01,2015-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,110000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2015.0,Q2,2015-04-01,2015-06-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,1000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2015.0,Q2,2015-04-01,2015-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-1312000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2015.0,Q3,2015-07-01,2015-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-14084000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-14084000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,241000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,253000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,5740000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-1370000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-9220000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2015.0,Q3,2015-07-01,2015-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-9220000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-1319000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,2000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,10640000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2015.0,Q3,2015-07-01,2015-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,9323000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2015.0,Q3,2015-07-01,2015-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,9323000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,50000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,50000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2015.0,Q3,2015-07-01,2015-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,50000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2015.0,Q3,2015-07-01,2015-09-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-14000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2015.0,Q3,2015-07-01,2015-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,139000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2015.0,Q4,2015-10-01,2015-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-14094000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-14094000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,306000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,210000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,4647000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-195000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-9126000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2015.0,Q4,2015-10-01,2015-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-9126000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-188000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,30250000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2015.0,Q4,2015-10-01,2015-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,30062000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2015.0,Q4,2015-10-01,2015-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,30062000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,145000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-420000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-275000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2015.0,Q4,2015-10-01,2015-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-275000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2015.0,Q4,2015-10-01,2015-12-31,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,11000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2015.0,Q4,2015-10-01,2015-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,20672000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:21:37+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-15392000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:21:37+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-15392000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:21:37+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,320000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:21:37+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,4073000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:21:37+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-1154000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:21:37+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-12153000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:21:37+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-12153000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:21:37+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-122000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:21:37+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,37738000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:21:37+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,37616000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:21:37+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,37616000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:21:37+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,262000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:21:37+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,262000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:21:37+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,262000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:21:37+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,9000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:21:37+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,25734000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2016.0,Q2,2016-04-01,2016-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-61660000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-61660000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,343000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,51923000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,1170000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-8224000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2016.0,Q2,2016-04-01,2016-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-8224000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-1004000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuinginvestingactivities,divestitures,Divestitures,+,debit,usd,3449000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2016.0,Q2,2016-04-01,2016-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,2445000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2016.0,Q2,2016-04-01,2016-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,2445000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,87000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,87000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2016.0,Q2,2016-04-01,2016-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,87000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2016.0,Q2,2016-04-01,2016-06-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-88000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2016.0,Q2,2016-04-01,2016-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-5780000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2016.0,Q3,2016-07-01,2016-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-14301000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-14301000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,453000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,3347000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,854000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-9647000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2016.0,Q3,2016-07-01,2016-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-9647000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-362000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2016.0,Q3,2016-07-01,2016-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-362000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2016.0,Q3,2016-07-01,2016-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-362000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,100000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-96000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,4000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2016.0,Q3,2016-07-01,2016-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,4000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2016.0,Q3,2016-07-01,2016-09-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-26000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2016.0,Q3,2016-07-01,2016-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-10031000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2016.0,Q4,2016-10-01,2016-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-22394000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-22394000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,487000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,12730000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,835000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-8342000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2016.0,Q4,2016-10-01,2016-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-8342000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-924000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2016.0,Q4,2016-10-01,2016-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-924000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2016.0,Q4,2016-10-01,2016-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-924000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,186000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,17000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,203000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2016.0,Q4,2016-10-01,2016-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,203000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2016.0,Q4,2016-10-01,2016-12-31,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-38000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2016.0,Q4,2016-10-01,2016-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-9101000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 16:25:07+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-16099000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 16:25:07+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-16099000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 16:25:07+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,516000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 16:25:07+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1965000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 16:25:07+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,1801000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 16:25:07+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-11817000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 16:25:07+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-11817000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 16:25:07+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-263000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 16:25:07+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-138591000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 16:25:07+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-138854000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 16:25:07+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-138854000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 16:25:07+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,187000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 16:25:07+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,187000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 16:25:07+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,187000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 16:25:07+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-117000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 16:25:07+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-150601000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2017.0,Q2,2017-04-01,2017-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-11430000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-11430000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,540000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,2358000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-2889000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-11421000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2017.0,Q2,2017-04-01,2017-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-11421000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-469000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-34197000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,14000000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2017.0,Q2,2017-04-01,2017-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-20666000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2017.0,Q2,2017-04-01,2017-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-20666000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,155000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,155000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2017.0,Q2,2017-04-01,2017-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,155000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2017.0,Q2,2017-04-01,2017-06-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-114000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2017.0,Q2,2017-04-01,2017-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-32046000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2017.0,Q3,2017-07-01,2017-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-13829000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-13829000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,536000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,419000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,2506000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,383000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-9985000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2017.0,Q3,2017-07-01,2017-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-9985000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-186000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-28250000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,31061000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2017.0,Q3,2017-07-01,2017-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,2625000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2017.0,Q3,2017-07-01,2017-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,2625000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,83000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-322000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-239000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2017.0,Q3,2017-07-01,2017-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-239000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2017.0,Q3,2017-07-01,2017-09-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-211000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2017.0,Q3,2017-07-01,2017-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-7810000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2017.0,Q4,2017-10-01,2017-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-14789000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-14789000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,504000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,174000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1867000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,46000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-12198000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2017.0,Q4,2017-10-01,2017-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-12198000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-98000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-8749000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,43538000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2017.0,Q4,2017-10-01,2017-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,34691000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2017.0,Q4,2017-10-01,2017-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,34691000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,16611000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,34000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,16645000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2017.0,Q4,2017-10-01,2017-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,16645000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2017.0,Q4,2017-10-01,2017-12-31,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-332000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2017.0,Q4,2017-10-01,2017-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,38806000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 16:13:24+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-17200000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 16:13:24+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-17200000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 16:13:24+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,459000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 16:13:24+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,0.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 16:13:24+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,3586000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 16:13:24+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,171000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 16:13:24+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-12984000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 16:13:24+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-12984000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 16:13:24+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-216000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 16:13:24+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-30374000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 16:13:24+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,55973000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 16:13:24+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,25383000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 16:13:24+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,25383000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 16:13:24+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,0.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 16:13:24+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,100000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 16:13:24+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,70191000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 16:13:24+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-493000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 16:13:24+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,69798000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 16:13:24+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,69798000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 16:13:24+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,82197000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2018.0,Q2,2018-04-01,2018-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-18810000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-18810000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,640000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,5589000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,1231000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-11350000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2018.0,Q2,2018-04-01,2018-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-11350000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-166000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-15762000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,30824000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2018.0,Q2,2018-04-01,2018-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,14896000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2018.0,Q2,2018-04-01,2018-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,14896000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-88000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,146000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,129000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,187000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2018.0,Q2,2018-04-01,2018-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,187000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2018.0,Q2,2018-04-01,2018-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,3733000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2018.0,Q3,2018-07-01,2018-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-20958000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-20958000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,262000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,199000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,8293000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-4696000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-16900000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2018.0,Q3,2018-07-01,2018-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-16900000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-270000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-9788000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,31196000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2018.0,Q3,2018-07-01,2018-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,21138000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2018.0,Q3,2018-07-01,2018-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,21138000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-30000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,1000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,14000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-15000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2018.0,Q3,2018-07-01,2018-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-15000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2018.0,Q3,2018-07-01,2018-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,4223000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2018.0,Q4,2018-10-01,2018-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-15659000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-15659000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,389000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,-175000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,2269000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,446000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-12730000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2018.0,Q4,2018-10-01,2018-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-12730000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-157000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-22802000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,30986000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2018.0,Q4,2018-10-01,2018-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,8027000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2018.0,Q4,2018-10-01,2018-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,8027000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-57000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,189000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-153000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-21000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2018.0,Q4,2018-10-01,2018-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-21000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2018.0,Q4,2018-10-01,2018-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-4724000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2019.0,Q1,2019-01-01,2019-03-31,2020-05-28 16:16:11+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-14489000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2019.0,Q1,2019-01-01,2019-03-31,2020-05-28 16:16:11+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-14489000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2019.0,Q1,2019-01-01,2019-03-31,2020-05-28 16:16:11+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,426000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2019.0,Q1,2019-01-01,2019-03-31,2020-05-28 16:16:11+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,-129000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2019.0,Q1,2019-01-01,2019-03-31,2020-05-28 16:16:11+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,3583000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2019.0,Q1,2019-01-01,2019-03-31,2020-05-28 16:16:11+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-2608000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2019.0,Q1,2019-01-01,2019-03-31,2020-05-28 16:16:11+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-13217000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2019.0,Q1,2019-01-01,2019-03-31,2020-05-28 16:16:11+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-13217000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2019.0,Q1,2019-01-01,2019-03-31,2020-05-28 16:16:11+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-2186000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2019.0,Q1,2019-01-01,2019-03-31,2020-05-28 16:16:11+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-22454000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2019.0,Q1,2019-01-01,2019-03-31,2020-05-28 16:16:11+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,27385000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2019.0,Q1,2019-01-01,2019-03-31,2020-05-28 16:16:11+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,2745000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2019.0,Q1,2019-01-01,2019-03-31,2020-05-28 16:16:11+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,2745000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2019.0,Q1,2019-01-01,2019-03-31,2020-05-28 16:16:11+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-28000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2019.0,Q1,2019-01-01,2019-03-31,2020-05-28 16:16:11+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,0.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2019.0,Q1,2019-01-01,2019-03-31,2020-05-28 16:16:11+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-342000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2019.0,Q1,2019-01-01,2019-03-31,2020-05-28 16:16:11+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-370000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2019.0,Q1,2019-01-01,2019-03-31,2020-05-28 16:16:11+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-370000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2019.0,Q1,2019-01-01,2019-03-31,2020-05-28 16:16:11+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-10842000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2019.0,Q2,2019-04-01,2019-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-14954000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-14954000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,420000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,793000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1927000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,226000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-11588000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2019.0,Q2,2019-04-01,2019-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-11588000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-2497000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-48095000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,14000000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2019.0,Q2,2019-04-01,2019-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-36592000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2019.0,Q2,2019-04-01,2019-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-36592000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-28000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,297000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,1612000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,1881000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2019.0,Q2,2019-04-01,2019-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,1881000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2019.0,Q2,2019-04-01,2019-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-46299000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2019.0,Q3,2019-07-01,2019-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-16118000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-16118000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,373000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,143000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,4347000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,1725000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-9530000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2019.0,Q3,2019-07-01,2019-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-9530000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-6191000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-62595000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,53770000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2019.0,Q3,2019-07-01,2019-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-15016000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2019.0,Q3,2019-07-01,2019-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-15016000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-28000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-63000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-91000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2019.0,Q3,2019-07-01,2019-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-91000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2019.0,Q3,2019-07-01,2019-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-24637000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2019.0,Q4,2019-10-01,2019-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-18925000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-18925000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,354000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,-2080000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,7686000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-1870000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-14835000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2019.0,Q4,2019-10-01,2019-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-14835000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-8373000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-64199000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,53362000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2019.0,Q4,2019-10-01,2019-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-19210000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2019.0,Q4,2019-10-01,2019-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-19210000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,0.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,0.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,0.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2019.0,Q4,2019-10-01,2019-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,26771000.0
Adverum Biotechnologies Inc,ADVM,,0001501756,2019.0,Q4,2019-10-01,2019-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-7274000.0
